1887

oa Southern African Journal of Anaesthesia and Analgesia - Do the COX-2 inhibitors still have a role to play? : guest editorial

Volume 11, Issue 2
  • ISSN : 2220-1181

 

Abstract

Extracted from text ... GUEST EDITORIAL Southern African Journal of Anaesthesia & Analgesia - May 2005 55 Do the COX-2 inhibitors still have a role to play? controlling effects. The search was therefore on for a COX-2 selective drug and the pot of gold that would accompany it. Celecoxib, a weakly COX-2 selective agent, was released in 1998 following trials lasting 3 - 6 months. Rofecoxib ("Vioxx"), the first highly COX-2 selective agent, was approved for release on 21 May 1999. Its release was based on studies of 6 months' duration showing anti-inflammatory and analgesic efficacy and improved GIT safety compared with NSNSAIDs. ..

Loading full text...

Full text loading...

Loading

Article metrics loading...

/content/medsajaa/11/2/EJC73474
2005-05-01
2016-12-11

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error